// App-Quantinova.ai

e12027 : Predictive role of clinical benefit (CB) at 1st line on the outcome of subsequent lines in metastatic breast cancer (MBC) patients: analysis of a real life population.

Researchers

Presenter

  • Ornella Garrone

Principal Investigators

  • Massimo Di Maio

  • Anna Maria Vandone

  • Rodolfo Brizio

  • Paola Vanella

  • Emanuela Miraglio

  • Alberto Comino

  • Marco Carlo Merlano

Medical Centers

  • Medical Oncology, S.Croce & Carle Teaching Hospital, Cuneo, Italy

  • Department of Oncology, University of Turin, Orbassano (TO), Italy

  • Department of Pathology, S. Croce & Carle Teaching Hospital, Cuneo, Italy

  • S. Croce & Carle Teaching Hospital, Cuneo, Italy

  • Medical Oncology, Oncology Department, S. Croce & Carle Teaching Hospital, Cuneo, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved